Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
NOT_YET_RECRUITING
NCT07619365
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
60
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
Advanced Breast Cancer
Metastatic Breast Cancer
RECRUITING
NCT02693535
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
4,200
Enrollment(s)
181
Study location(s)
INTERVENTIONAL (PHASE2)
Lymphoma, Non-Hodgkin
Multiple Myeloma
Advanced Solid Tumors
RECRUITING
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
18
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE1)
Gastric Cancer
Gastrointestinal Cancer
HER2 Gene Mutation
RECRUITING
NCT06769490
Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
44
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Acute Myeloid Leukemia
NOT_YET_RECRUITING
NCT07825753
Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast Cancer
225
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced or Metastatic Pancreatic Adenocarcinoma
Advanced or Metastatic Breast Cancer (BC)
RECRUITING
NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
130
Enrollment(s)
64
Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
Leukemia
RECRUITING
NCT07678957
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
120
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
RECRUITING
NCT06727227
Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer
138
Enrollment(s)
14
Study location(s)
OBSERVATIONAL (None)
Breast Cancer
6
7
8
9
10